Patents by Inventor Kimberly R. Cordes

Kimberly R. Cordes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9364506
    Abstract: The present disclosure provides methods of inducing smooth muscle cell differentiation. The present disclosure provides genetically modified cells comprising exogenous miR-143 and/or miR-145 nucleic acids; and artificial tissues comprising the genetically modified cells. The present disclosure provides methods and compositions for reducing pathological angiogenesis. The present disclosure provides methods of inducing therapeutic angiogenesis. The present disclosure provides methods, compositions, and devices for inhibiting vascular smooth muscle cell proliferation.
    Type: Grant
    Filed: May 20, 2014
    Date of Patent: June 14, 2016
    Assignee: The J. David Gladstone Institutes
    Inventors: Deepak Srivastava, Kimberly R. Cordes
  • Publication number: 20150037290
    Abstract: The present disclosure provides methods of inducing smooth muscle cell differentiation. The present disclosure provides genetically modified cells comprising exogenous miR-143 and/or miR-145 nucleic acids; and artificial tissues comprising the genetically modified cells. The present disclosure provides methods and compositions for reducing pathological angiogenesis. The present disclosure provides methods of inducing therapeutic angiogenesis. The present disclosure provides methods, compositions, and devices for inhibiting vascular smooth muscle cell proliferation.
    Type: Application
    Filed: May 20, 2014
    Publication date: February 5, 2015
    Applicant: The J. David Gladstone Institutes
    Inventors: Deepak Srivastava, Kimberly R. Cordes
  • Patent number: 8735568
    Abstract: The present disclosure provides methods of inducing smooth muscle cell differentiation. The present disclosure provides genetically modified cells comprising exogenous miR-143 and/or miR-145 nucleic acids; and artificial tissues comprising the genetically modified cells. The present disclosure provides methods and compositions for reducing pathological angiogenesis. The present disclosure provides methods of inducing therapeutic angiogenesis. The present disclosure provides methods, compositions, and devices for inhibiting vascular smooth muscle cell proliferation.
    Type: Grant
    Filed: March 8, 2010
    Date of Patent: May 27, 2014
    Assignee: The J. David Gladstone Institutes
    Inventors: Deepak Srivastava, Kimberly R. Cordes
  • Publication number: 20120093789
    Abstract: The present disclosure provides methods of inducing smooth muscle cell differentiation. The present disclosure provides genetically modified cells comprising exogenous miR-143 and/or miR-145 nucleic acids; and artificial tissues comprising the genetically modified cells. The present disclosure provides methods and compositions for reducing pathological angiogenesis. The present disclosure provides methods of inducing therapeutic angiogenesis. The present disclosure provides methods, compositions, and devices for inhibiting vascular smooth muscle cell proliferation.
    Type: Application
    Filed: March 8, 2010
    Publication date: April 19, 2012
    Inventors: Deepak Srivastava, Kimberly R. Cordes